Discovery mi scanner
The Discovery MI scanner is a positron emission tomography (PET) imaging system developed by GE Healthcare. It is designed to provide high-quality, three-dimensional images of the body's internal structures and functions. The scanner uses specialized detectors and computer algorithms to capture and analyze the distribution of radioactive tracer materials within the patient's body, allowing healthcare professionals to diagnose and monitor a variety of medical conditions.
Lab products found in correlation
12 protocols using discovery mi scanner
Standardized FDG-PET/CT and PET/MR Protocols
Standardized Tau-PET Imaging Protocol
11C-PIB PET/CT Imaging Protocol
PSMA-PET/CT Imaging Protocols
Amyloid PET and CSF Aβ Measurements
Tau Deposition Assessment in Alzheimer's Disease
In order to capture brain areas affected by tau deposition over the course of AD, three composite FreeSurfer-based regions-of-interest (ROI) were created according to the Braak tau pathology staging scheme21 (link). These include region I-II (the entorhinal cortex and hippocampus), region III-IV (parahippocampal cortices, fusiform cortices, amygdala, as well as the inferior and the middle temporal cortices), and region V-VI (widespread neocortical areas)22 (link). In a secondary analysis, regional associations between MBI-C total scores and [18F]RO948 SUVR were assessed using voxel-wise multiple regression models, including age, sex, education, and white matter volume as covariates, as implemented in SPM12 (
Dual-Time Point PET/CT Imaging of Ovarian and Breast Cancers
Multimodal Imaging of Sinonasal Pathologies
Radiosynthesis and PET Imaging of [68Ga]FAPI-46
Preceded by a low-dose non-CECT scan for attenuation correction, PET images were acquired from vertex to mid thigh (4 min/bed position). The obtained emission data were corrected for scatter, randoms, and decay and were reconstructed with an ordered-subset expectation maximization algorithm. The reconstruction parameters were carefully designed to ensure equivalent (within 610% variation) SUV and contrast in a PET body phantom with spheres. Finally, diagnostic CECT was performed for anatomic correlation of PET findings and diagnostic-quality image fusion.
Multimodal PET Imaging of Amyloid-β
Participants underwent 18F-flutemetamol PET and 18F-RO948 PET on Discovery MI scanners (GE healthcare). 18F-flutemetamol PET images were acquired 90 to 110 min after injection of 185 MBq 18F-flutemetamol, whereas 18F-RO948 PET images were acquired 70 to 90 min after injection of 370 MBq 18F-RO948. Pre-processing and generation of standardized uptake value ratio (SUVRs) maps were carried out as previously described.32 (link),33 (link)18F-Flutemetamol scans were normalized using the Pons as reference region, whereas 18F-RO948 images were referenced to the inferior cerebellar grey matter. For all subjects, Aβ status was defined based on the average SUVR values from a cortical composite using a previously published cut-off of 0.53.32 (link)
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!